Pfizer (PFE +3.16%) and Novo Nordisk (NVO 0.44%) are large. Very large. They make pills. Lots of them. Both have had a bit of trouble lately, which is what happens to everything eventually. Pfizer’s Covid bump is fading, which is a shame for their shareholders, but predictable. Novo Nordisk lost some ground in the weight-loss game, which is a bit like losing at being hungry. At their current prices, though, they’re worth a look. A cautious look, mind you.
Within this vast portfolio, a curious anomaly presents itself. Nearly thirty percent allocated to a single stock – not the very company that seeded the fortune, but a conglomerate, a behemoth of diversified holdings, a name synonymous with value investing: Berkshire Hathaway. It is a paradox, isn’t it? To build a legacy of giving, yet to remain tethered to the fluctuations of the market, to the whims of capital. One begins to suspect a deeper entanglement, a psychological dependence even, upon the very system one seeks to ameliorate.
Look, the tech world is having a moment. It’s like a teenager discovering credit cards. Everyone’s convinced AI is the next big thing, and nobody wants to be the Blockbuster of the future. Remember Blockbuster? They had a perfectly good business model, and then someone invented streaming. It’s tragic, really. Like watching a golden retriever try to do calculus.
There’s a good deal of head-scratching going on, naturally, as to where this digital currency is headed. But to suggest utter panic would be a bit strong. Bitcoin, you see, is a resilient sort. It’s taken a tumble or two before and bounced back with a vim and vigour that would make a spring lamb envious. And that, my friends, is a point worth pondering.
The WisdomTree U.S. Total Dividend ETF, which we’ll use as a sort of proxy for the entire dividend universe (mostly because it has a pleasingly bureaucratic name), managed a respectable 50% total return from 2023 to 2025. But then, the Vanguard S&P 500 ETF went and achieved 86%. It’s a bit like comparing a reasonably efficient bicycle to a rocket-propelled unicycle. Both get you somewhere, but one does it with a disturbing lack of subtlety. (And a significantly higher chance of spontaneous combustion.)
Coca-Cola’s longevity—over a century of operation—is frequently cited as evidence of its enduring strength. However, a more nuanced perspective recognizes that survival alone does not guarantee future prosperity. The company’s primary asset remains its globally recognized brand, which affords a degree of pricing power and consumer loyalty. The consistent consumption of 2.2 billion servings daily suggests a deeply ingrained consumer habit. However, this habit is not impervious to change. Shifts in consumer preferences towards healthier alternatives, coupled with evolving distribution channels, represent ongoing challenges.
The filing with the Securities and Exchange Commission—a document as thrilling as a treatise on beige—reveals an acquisition of 221,679 shares. This constitutes a rather substantial sum – $13.2 million, to be precise – or, as I prefer to think of it, a small fortune devoted to the creation of… things. It represents 3.1% of G2’s assets under management, a figure that speaks volumes about their confidence, or perhaps their boredom.
To observe the current valuations within the electric vehicle landscape is to witness a peculiar imbalance. Rivian, after a recent correction, finds itself diminished to a market capitalization of a mere $18 billion – a sum that, while substantial in many contexts, pales in comparison to the behemoth that is Tesla. The latter, a veritable titan of industry, commands a valuation exceeding $1.2 trillion. The ratio of their respective market values – a gulf of sixty-seven to one – is a stark reminder of the capricious nature of investor sentiment.
Revenue is up 20% in the last quarter, hitting $271.2 million. Which is…good. It’s definitely good. It was roughly what they expected, so no major catastrophes there. Annual Recurring Revenue (ARR) climbed 21% to $1.119 billion. Which sounds impressive when you say it fast. They added $64 million in new ARR. I added approximately zero to my savings account this month, so, you know, perspective. The number of customers spending over $100,000 has gone up 18% to 1,667. I’m pretty sure my average monthly spending is higher than that, but let’s not dwell.
I suspect two further contenders will join their ranks within the next three years. Taiwan Semiconductor Manufacturing (TSM) and Broadcom (AVGO), both purveyors of essential components for the increasingly frantic world of digital conjuring. They have some way to go, mind you. TSMC currently boasts a valuation of $1.75 trillion, Broadcom a respectable $1.59 trillion. To reach the three trillion mark, they require growth of 71% and 89% respectively. A significant undertaking, but not entirely improbable. Especially when one considers the sheer, unbridled demand for… well, everything digital.2